A Bio-bank for Patients with Inflammatory Bowel Disease Associated Neoplasia

Overview

Información sobre este estudio

The purpose of this study is to collect blood and stool samples to validate and improve the performance of stool and blood DNA markers for inflammatory bowel disease and colorectal neoplasia critical to the long-term goal of improving effectiveness of neoplasia detection in patients using non-invasive biomarkers to assist colonoscopy and radiographic screening. 

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria

  • A diagnosis of ulcerative colitis or Crohn’s or indeterminate colitis with known dysplasia or cancer
  • A clinical evaluation with a colonoscopy or surgery scheduled within 120 days of sample collection
  • Has had a clinical evaluation colonoscopy within the last 120 days before sample collection

Exclusion Criteria 

  • Younger than 18 years of age
  • Has undergone a biopsy of the target neoplastic pathology in the last 7 days (relative contraindication)
  • Has undergone a therapeutic intervention to treat or remove the target pathology
  • Has received chemotherapy class drugs or therapeutic radiation in the last 5 years
  • Has a primary cancer diagnosis anywhere in the body in the last 5 years (non-including non-melanoma skin cancer) (ineligible for blood collection)
  • Has cancer of the mouth, esophagus, lung or GI tract (ineligible for stool collection)
  • Has Barrett’s esophagus (ineligible for stool collection)
  • Has ileostomy (ineligible for stool collection)
  • Is currently on a non-oral diet (using G or J tube or TPN) (ineligible for stool collection)

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

John Kisiel, M.D.

Abierto para la inscripción

Contact information:

Kari Lowrie

(507)266-3778

Lowrie.Kari@mayo.edu

More information

Publicaciones

Publications are currently not available
.
CLS-20304536

Mayo Clinic Footer